Tag: drug

Posted on

GSK gets good news on asthma drug – Triangle Business Journal

GSK gets good news on asthma drug
Triangle Business Journal
GlaxoSmithKline (NYSE: GSK) announced statistically significant Phase 3 results for Relovair, an asthma treatment that the British drug giant is developing with partner Theravance Inc. (NASDAQ: THRX). Relovair is a once-daily inhaled treatment for …
Glaxo Drug Gets Positive Trial ResultsWall Street Journal
Theravance, Glaxo Lung Drug Passes Two Pivotal Trials; Two More to GoXconomy
Glaxo reports positive results for inhaler drugForbes

all 30 news articles »

View full post on asthma – Google News

Posted on

Researchers find link between flu, asthma – Drug Store News


MedIndia

Researchers find link between flu, asthma
Drug Store News
BOSTON — Researchers at Children's Hospital Boston have discovered the reason why influenza may induce asthma attacks among children. A team led by senior investigator Dale Umets found that the flu can activate a newly recognized group of immune cells …
Biological Trials linked to Viral Infection in Asthma PatientsTopNews United States
Why influenza induces asthma attacks?Times of India
Study reveals asthma's viral triggerABC Online
eMaxHealth –TruthDive –News Tonight
all 51 news articles »

View full post on asthma – Google News

Posted on

Verona Pharma starts asthma drug Phase II trial – Pharmaceutical Business Review

Verona Pharma starts asthma drug Phase II trial
Pharmaceutical Business Review
Verona Pharma has started a Phase II trial of its respiratory drug RPL554 to determine if the drug has sustained bronchodilator actions, and is safe when given daily to patients who are suffering from mild asthma. The company has also treated first …
Verona Pharma starts new trial of lead drugStock Market Wire

all 4 news articles »

View full post on asthma – Google News

Posted on

Pfizer returns asthma drug development to Rigel – Ventura County Star

Pfizer returns asthma drug development to Rigel
Ventura County Star
(AP) – Rigel Pharmaceuticals Inc. said Friday it will take over development from Pfizer Inc. of a potential allergic asthma treatment that recently completed several early-stage clinical trials. The South San Francisco, Calif., development-stage …
Rigel Assumes Development Responsibility For Inhaled AsthmaBioResearch Online (press release)
Losing Biobucks as Pharma Reshuffles Its DeckSeeking Alpha
Pfizer returns asthma drug candidate rights to Rigel Pharma; latter narrows lossesThe Pharma Letter
Pharma Times
all 6 news articles »

View full post on asthma – Google News

Posted on

CDC, partners reinforce World Asthma Day’s message take control of asthma – Drug Store News


AccessRx Health Blog (blog)

CDC, partners reinforce World Asthma Day's message take control of asthma
Drug Store News
ATLANTA — The number of people diagnosed with asthma in the United States grew by 4.3 million between 2001 and 2009, according to a new Vital Signs report released earlier this week by the Centers for Disease Control and Prevention. …
Implications for Sacramento of 2011 national asthma trendsExaminer.com
Illinois Residents with Asthma Threatened by Potential Federal Budget CutsPR Newswire (press release)
Asthma Rates Up Despite Smoke-Free LawsKTVA CBS 11 News Alaska
Natural Resources Defense Council (blog) –Hispanically Speaking News –News on Wellness
all 30 news articles »

View full post on asthma – Google News

Posted on

Pfizer returns asthma drug development to Rigel – Forbes

Pfizer returns asthma drug development to Rigel
Forbes
Rigel Pharmaceuticals Inc. said Friday it will take over development from Pfizer Inc. of a potential allergic asthma treatment that recently completed several early-stage clinical trials. The South San Francisco, Calif., development-stage company said …
Rigel says Pfizer returns asthma therapy rightsReuters
Rigel Assumes Development Responsibility for Inhaled Asthma TherapyPR Newswire (press release)
Pfizer returns allergic asthma drug to RigelFierceBiotech
Xconomy
all 27 news articles »

View full post on asthma – Google News

Posted on

Pfizer returns allergic asthma drug to Rigel – FierceBiotech

Pfizer returns allergic asthma drug to Rigel
FierceBiotech
Pfizer's decision to ends its allergy and respiratory R&D work has prompted the company return rights to the R343 program for allergic asthma to Rigel Pharmaceuticals. The drug has shown promise in Phase I trials and Rigel plans to begin designing a …
Rigel says Pfizer returns asthma therapy rightsReuters
Rigel Assumes Development Responsibility for Inhaled Asthma TherapyPR Newswire (press release)
Pfizer Hands Back Rigel DrugXconomy

all 16 news articles »

View full post on asthma – Google News